Head-to-head · Cost-Efficiency Index
Sesame Care vs Breeze Meds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Sesame Care
People who want FDA-approved Wegovy, Zepbound or the Foundayo pill, a provider they pick themselves, and the option to collect it at a local pharmacy the same day.
Visit Sesame CareBreeze Meds
People who want to independently verify the clinicians and pharmacy behind their GLP-1 — and who'll pay a mid-market price for that paper trail plus FSA/HSA eligibility.
Visit Breeze MedsThe verdict
Sesame Care and Breeze Meds tie on the Cost-Efficiency Index at 86/100, so neither wins outright on the numbers, so choose on fit. Sesame Care: People who want FDA-approved Wegovy, Zepbound or the Foundayo pill, a provider they pick themselves, and the option to collect it at a local pharmacy the same day. Breeze Meds: People who want to independently verify the clinicians and pharmacy behind their GLP-1 — and who'll pay a mid-market price for that paper trail plus FSA/HSA eligibility.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Sesame Care.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Sesame Care | Breeze Meds |
|---|---|---|
| Cost-Efficiency Index | 86/100 | 86/100 |
| Semaglutide / mo | $149/moMedication + $59/mo care subscription (that rate needs a 12-month commitment) | $199/mo |
| Tirzepatide / mo | Brand (Zepbound) | $399/moOn the product grid; the post-intake screen shows $299 — Breeze publishes both |
| Semaglutide / yr (modeled) | — | $2,388 |
| Tirzepatide / yr (modeled) | — | $4,788 |
| Coverage | Nationwide | All 50 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #7 | #13 |
Sesame Care
86/100Where the value is
- Brand-name choices include the Wegovy pill and pen, Wegovy HD, Zepbound vials and KwikPen, and the Foundayo pill
- Medication starts at $149 a month for the Wegovy pill or Foundayo and $299 for a Zepbound vial or KwikPen
- You choose your own provider, meet by video, and get lab work when your provider wants metabolic data
The tradeoffs
- Two separate charges: the care plan and the medication are billed apart, so the floor is about $208 a month, not $149
- The $59 care price needs a 12-month commitment; month to month it is $99, or $79 on three months and $69 on six
Breeze Meds
86/100Where the value is
- Names its doctors (Lion MD group) and its dispensing pharmacies, both checkable, and is LegitScript certified
- All 50 states, with injectable semaglutide from $199/mo plus oral semaglutide (~$299) and oral tirzepatide (~$399) for the needle-averse
- FSA/HSA eligible, which trims the effective monthly cost
The tradeoffs
- Mid-to-higher per-month pricing — tirzepatide and the oral routes carry a premium over the cheapest all-50 rivals
- Compounded only — not FDA-approved brand-name medication
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.